2026 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

2026 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Jan 24, 2026
Last Review
Jan 24, 2026
Expires
Jan 24, 2027

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

Faculty & Disclosure

Faculty

Mark Pegram, MD

Accreditation

NA